- Name: Xie Jingdun
- Title: Vice Chief of the Department
- Email: xiejd@sysucc.org.cn
- Phone:
Profile
Dr. Xie graduated from Zhongshan School of Medicine, SYSU in 2006. He pursued his advanced studies in MD Anderson cancer center in the United States. He has carried out and participated in a multitude of research and clinical work. He mainly researches the mechanism of pain, and the relation between pain and immunity, as well as pain intervention therapy. Currently He is undertaking programs, including National Natural Science Foundation of China.
Interests
Mechanisms of pain, and the relationship between pain and immunity.
Education
Publications
(1) Xie JD, Chen SR, Pan HL. Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain. Journal of Biological Chemistry, 2017.12.1 5, 292(50): 20644-20654.
(2) Xie JD, Chen SR, Chen H, Zeng WA, Pan HL. Presynaptic N-Methyl-d-aspartate (NMDA) receptor activity is increased through protein kinase C in paclitaxel-induced neuropathic pain. Journal of Biological Chemistry, 2016.9.9, 291(37): 19364-19373.
(3) Xie JD, Chen SR, Chen H, Pan HL. Bortezomib induces neuropathic pain through protein kinase C-mediated activation of presynaptic NMDA receptors in the spinal cord. Neuropharmacology, 2017.9.1, 1(123): 477-487.
Updated June 2022 by International Office, Sun Yat-sen University Cancer Center